Hui-Li Wang Selected Research

Mood Disorders (Mood Disorder)

5/2007

D-serine relieves chronic lead exposure-impaired long-term potentiation in the CA1 region of the rat hippocampus in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Li Wang Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2020
3	Neoplasms (Cancer) 09/2019 - 06/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2021 - 06/2009
2	Inflammation (Inflammations) 05/2021 - 01/2018
2	Adenocarcinoma of Lung 09/2019 - 01/2018
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2015 - 02/2014
2	Body Weight (Weight, Body) 09/2013 - 06/2010
1	Non-alcoholic Fatty Liver Disease 07/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2022
1	Obesity 07/2022
1	Disease Progression 01/2022
1	Dysbiosis 01/2022
1	Infections 10/2021
1	Mastitis 05/2021
1	Optic Atrophy 04/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Anxiety Disorders (Anxiety Disorder) 01/2020
1	Sleep Deprivation 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019
1	Iron Deficiencies 01/2019
1	Mouth Neoplasms (Oral Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Carcinogenesis 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2017
1	Cognitive Dysfunction 01/2017
1	Sepsis (Septicemia) 12/2016
1	AIDS-Related Complex (ARC) 01/2016
1	Cardiomyopathies (Cardiomyopathy) 08/2014
1	Nervous System Diseases (Neurological Disorders) 02/2014
1	Chronic Pain 09/2012
1	Pain (Aches) 09/2012
1	Melanoma (Melanoma, Malignant) 06/2010
1	Experimental Melanoma 06/2010
1	Skin Neoplasms (Skin Cancer) 06/2010
1	Mood Disorders (Mood Disorder) 05/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2014
3	IronIBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 05/2021 - 06/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 09/2019 - 01/2018
2	Histones (Histone)IBA 05/2015 - 02/2014
1	LipidsIBA 07/2022
1	bisphenol AIBA 07/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	FlavonoidsIBA 05/2021
1	EnzymesIBA 05/2021
1	Caspase 3 (Caspase-3)IBA 05/2021
1	dihydromyricetinIBA 05/2021
1	RotenoneIBA 10/2020
1	Dynamins (Dynamin)IBA 04/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	CannabinoidsIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	trioctyl trimellitate (TOTM)IBA 01/2020
1	RimonabantIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 09/2019
1	Tyrosine Kinase InhibitorsIBA 09/2019
1	TOR Serine-Threonine KinasesIBA 09/2019
1	Angiogenesis InhibitorsIBA 01/2018
1	Cyclin D1IBA 01/2018
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2018
1	MelatoninIBA 01/2018
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	OvalbuminIBA 01/2018
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2018
1	VimentinIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	AntioxidantsIBA 01/2017
1	LipopolysaccharidesIBA 12/2016
1	ORALIT (ORS)IBA 12/2016
1	Toll-Like Receptor 4IBA 12/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	asaroneIBA 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	Uncoupling Protein 2IBA 08/2014
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 09/2013
1	Formaldehyde (Formol)FDA Link 09/2012
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 09/2012
1	azasteneIBA 09/2012
1	Morphine (MS Contin)FDA LinkGeneric 09/2012
1	arsenic disulfide (realgar)IBA 06/2010
1	EstersIBA 06/2009
1	ethyleneIBA 06/2009
1	Vitamin E FDA LinkGeneric 06/2009
1	AcidsIBA 06/2009
1	Serine (L-Serine)FDA Link 05/2007

Therapy/Procedure

1	Oral Administration 07/2022
1	Transplantation 01/2022
1	Intraperitoneal Injections 01/2020
1	Length of Stay 04/2017
1	Therapeutics 02/2014
1	Analgesia 09/2012